{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:47:59Z","timestamp":1792511279112,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cmi.2026.10.010","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:24:54Z","timestamp":1792509894000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u2018Pharmacokinetics, target attainment and outcomes of piperacillin\/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis\u2019 \u2013 Author\u2019s reply"],"prefix":"10.1016","author":[{"given":"Ute","family":"Chiriac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto R.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G.","family":"Wicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.10.010_bib1","article-title":"Piperacillin alone may not tell the whole story: should we also monitor tazobactam?","author":"Cojutti","year":"2026","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.10.010_bib2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.3390\/antibiotics12121736","volume":"12","author":"Gatti","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.cmi.2026.10.010_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/34.4.555","article-title":"Inhibition of the renal excretion of tazobactam by piperacillin","volume":"34","author":"Komuro","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2026.10.010_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2017.12.037","article-title":"OAT1 and OAT3 also mediate the drug-drug interaction between piperacillin and tazobactam","volume":"537","author":"Wen","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cmi.2026.10.010_bib5","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01404-23","article-title":"Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin\/tazobactam against extended spectrum beta-lactamase producing Enterobacterales","volume":"68","author":"Cojutti","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.cmi.2026.10.010_bib6","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/j.cmi.2026.04.010","article-title":"Pharmacokinetics, target attainment, and outcomes of piperacillin\/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis","volume":"32","author":"Chiriac","year":"2026","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.cmi.2026.10.010_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chest.2023.03.046","article-title":"A Large-Scale Multicenter Retrospective Study on Nephrotoxicity Associated With Empiric Broad-Spectrum Antibiotics in Critically Ill Patients","volume":"164","author":"Chen","year":"2023","journal-title":"Chest"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26005835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:24:55Z","timestamp":1792509895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26005835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":7,"alternative-id":["S1198743X26005835"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.10.010","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u2018Pharmacokinetics, target attainment and outcomes of piperacillin\/tazobactam in critically ill patients receiving continuous infusion with therapeutic drug monitoring: a retrospective analysis\u2019 \u2013 Author\u2019s reply","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.09.036","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}